Clinical Trials Browser

Phase 1/2 × OTHER × Human Epidermal Growth Factor 2 Negative Carcinoma of Breast × Clear all

NCT02871791 2022-08-29

Palbociclib With Everolimus + Exemestane In BC

Phase 1/2 Completed

41 enrolled 12 charts

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast